Eurofins Clinical Genetics >> Genetic Services >> PreNatSure-NIPS Plus

PreNatSure-NIPS Plus

Sidebar Image

Microdeletion syndromes cause severe health issues including dysmorphism, global developmental delay and intellectual disability. Early information helps patients & clinicians greatly in pregnancy management. cfDNA analysis using MPS detects fetal chromosomal aneuploidies & clinically significant microdeletions with high specificity and sensitivity.

 

PreNatSure – NIPS Plus

Non-invasive prenatal screening for chromosomal aneuploidies and 6 clinically significant microdeletion syndromes

Common Fetal Chromosomal Aneuploidies

Microdeletion Syndrome

Chromosomal Region

Trisomy21

Down syndrome

DiGeorge syndrome

22q11.2

Trisomy18

Edwards syndrome

1p36 deletion syndrome

1p36

Trisomy13

Patau syndrome

Angelman syndrome

15q 11.2

MonosomyX

Turner syndrome

Prader-Willi syndrome

15q 11.2

XXX

Trisomy X

Cri du Chat syndrome

5p15.3

XXY

Klinefelter syndrome

Wolf-Hirschhorn syndrome

4p 16.3

XYY

Jacobs syndrome

 

 

 

PreNatSure – NIPS Plus Advantages:

  • Early Screening: High risk patients with gestational age of 10th week
  • Advanced Technology: Uses proprietary NIPS technology
  • High Accuracy: 40-50 million reads / sample
  • Reliable: Sensitivity & specificity > 99%
  • Diagnostic Outcome: Low false positive & false negative ~0.2%
  • Stringent QC: 70+ QC check points
  • Low Risk: Only 10ml blood sample is required
  • Faster TAT: 9 working days